View
8
Download
0
Category
Preview:
Citation preview
Kidney Cadaveric 1969
Living 1980
Cornea 1961
Liver Cadaveric 1991
Living 1993
Bone 1991
Heart 1992 Skin 1992
Lung 1995 Pancreas NYD
Heart / Lung 1995 Gut NYD
Neuro NYD
n deceased
n living
Renal Transplantation Performed in HK
1 2 0 2 0 5 2 0 3 312
6 7 6 413 12
18 1724
33 32 34 31
44 44
5847
33
4741
48
73
44 4451 53 57
66
87
74
57
0 0 0 0 0 0 0 0 0 0
11 0
01 1
2 15
19
31
2423 35
44 42
42 63 65
92
151
201 184
169159
127
204
97
130
98
60
61
0
50
100
150
200
250
300
70 72 74 76 78 80 82 84 86 88 90 92 94 96 98 '00 '02 '04 '06 '08 '10
n HK living n HK deceased
n Outside HK
Renal Transplantation Followed-up in HK
0200400600800
1000120014001600180020002200240026002800300032003400
87 88 89 90 91 92 93 94 95 96 97 98 99 '00 '01 '02 '03 '04 '05 '06 '07 '08 '09 '10 '11
HK deceased HK living China Others
0
1000
2000
3000
4000
5000
6000
84
86
88
90
92
94
96
98
'00
'02
'04
'06
'08
'10
Number on dialysis
Number transplanted
0
5
10
15
20
25
30
最長輪候期 16 17 18 19 20 21 21 22 22 23 24 25 26 27 28 28 28 28 28
93 94 95 96 97 98 99 '00 '01 '02 '03 '04 '05 '06 '07 '08 '09 '10 '11
Number of Organs Available
Graft & Patient Survival
Extended Criteria Living Donation
Deceased Donation Rate
Recipient Matching Cold Ischemic Time
Immunosuppressants Manage Co-morbidities
ExtendedCriteriaDonor
StandardCriteriaDonor
UNOS- Age>60 or Age >50 + 2 out of 3 (stroke / HT / creatinine >130umol/L)
Include all unfavorable medical conditions
152 (41.2%)
217 (58.8%)
79 (24.9%)
277 (75.1%)
Total: 369
Act of donation should be regarded as heroic and honored
Shorten time for living donor evaluation
Hospitalization and renal transplantation operation fee waived for living donor
Life Long follow-up
Living donor with renal failure support with dialysis
& priority for access to renal transplantation
Promote pre-emptive renal transplant
Expand source of donors e.g. elderly donors, donors with mild BP, unrelated donors & paired exchange donors
0
10
20
30
40
50
60
70
A 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Contribute ~40% of all donors
No. of deceased organ donor amongst 15 H.A. acute hospitals (2003 - 2007)
21
2527
31
44
2628 29 30 29
7
108
16 16
12 1113
1513
0
5
10
15
20
25
30
35
40
45
50
98 99 '00 '01 '02 '03 '04 '05 '06 '07
H.K. A
Successful donors
Directly proportional to number of referrals
Stroke (70%)
50% from Neurosurgery or Medical ward
77% of potential donors missed
Majority of potential donors not admitted into ICU but cared in general wards (50% failed to reach brain death due to poor donor maintenance)
Nurses and transplant co-ordinators (and early rapport) important
Awareness of the general ward nurses are vital for more referrals
Overlook organ procurement and transplant
Set policies and guidelines and unify practice
Four major directions of work
Alignment of donor assessment and acceptance
Alignment of donor maintenance
Assuring support to transplant co-ordinators
Boosting referral rate and organ donation rate through improving coordination
Alignment of donor assessment and acceptance
Standardize donor acceptance criteria Standardize donor assessment and
investigation protocols Standardize referral initiation to initiate
donor maintenance early
Assuring support to transplant co-ordinators
Formation of Cluster Transplant Committee to establish the local donor
maintenance policy Smooth out logistics and support in referring, assessing and maintaining
potential donors
Alignment of donor maintenance Standardize the donor maintenance
protocol Endorse the role of transplant co-
ordinator to assist the parent team doctors in donor maintenance and
monitoring
Boosting referral rate and organ donation rate through improving coordination
Increase number of transplant co-ordinatiors from 4 to 5 (2008) to 7 (2009)
Pool call system of the transplant co-ordinators to increase efficiency
Region 1 Region 2 Region 3 Region 4 Region 5 Region 6 Region 7
*Queen Mary
Hospital
Pamela
Youde
Nethersole
Eastern
Hospital
*Queen
Elizabeth
Hospital
United
Christian
Hospital
*Prince of
Wales
Hospital
*Princess
Margaret
Hospital
Tuen Mun
Hospital
Ruttonjee &
Tang Shiu
Kin Hospital
Tseung
Kwan O
Hospital
Alice Ho Miu
Ling
Nethersole
Hospital
Caritas
Medical
Centre
Pok Oi
Hospital
North
District
Hospital
Kwong Wah
Hospital
Yan Chai
Hospital
Seminar to all Hospital Authority staff on organ procurement and donation
Seminars to hospital nurses
CENTRALIZED ORGAN DONATION REGISTER
C.O.D.R.
「捐器官, 我願意」器官捐贈推廣
活動
April 2006
Appeal thro’ Radio Television HK
Press Conference
全球同步支持器官捐贈日暨向捐贈者
致敬晚會
October 2008
Thanks Giving Ceremony
January 2010
Best Organ Donation Rate
in 2009
Cerebrating 100 heart transplants in HK
December 2009
Chinese Transplant Games World Transplant Games
2007
Bangkok
21 pt
17medals
2009
Australia
43 pt
45medals
2011
Sweden
37 pt
43medals
2006
Wuhan
10 pt
1 medal
2008
Shanghai
31 pt
24medals
2010
Tianjin
45 pt
46medals
Cable TV
RTHK
Press Conference
WTGF
3347
4149
74
42 4451 53 58
65
87
12
14
15
1918
23
30
18 19
23 2326
26
43
4758
0
10
20
30
40
50
60
70
80
90
100
110
120
130
140
150
1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009
Kidney Liver Heart Lung
Data from Organ Procurement System, Hong Kong Hospital Authority
0
1
2
3
4
5
6
7
8
69 71 73 75 77 79 81 83 85 87 89 91 93 95 97 99 '01 '03 '05 '07 '09
Medical & Health Department Hospital Authority
2 TC
Renal
Liver
Heart Lung
4 TC
CTC
7 TC
5 TC
2009
Spain 34.4 USA 26.1 UK 15.5 Australia 13.8 (2010) Canada 13.7 (2010)
Taiwan 8.5 (2008)
Hong Kong 7.5
Singapore 4.6 Malaysia 1.4 Source: www.tpm.org
Number of Organs Available
Graft & Patient Survival
Extended Criteria Living Donation
Deceased Donation Rate
Recipient Matching Cold Ischemic Time
Immunosuppressants Manage Co-morbidities
QMH PMH QEH
12 10.3 9.6
17
13.4 13.4
0
2
4
6
8
10
12
14
16
18
QMH PMH QEH
1st Kidney 2nd Kidney
9.9 9.3 9.3
0
2
4
6
8
10
12
14
16
18
QMH PMH QEH
Overall
2010 2011
0.5
0.6
0.8
0.9
1.0
0 1 2 3 4 6 7 8 9 10
Graft Survival, First RTx, - HLA Matching - Death Not Censored
Time in Years
Sur
viva
l Pro
babi
lity
6 mm
5 mm
4 mm
3 mm
2 mm
1 mm
0 mm
Hong Kong Result
Guarding
Recipient
Against
Failed
Transplant
Graft Survival Rate vs HLA Antibody Testing
95%
79%
75% 74%
99%93%
89%
50%
60%
70%
80%
90%
100%
0 1 2 3 4 5 6
Years after Transplant
% G
raft
Su
rviv
al
90%
HLA Antibody Absent
HLA Antibody Present
•Improve graft survival •Meet international Standards •Meet increasing transplant demand •Utilize contemporary antibody detection technology •Improve 5-year graft survival from 83% to 88%
Pre-transplant HLA antibody screening: From 6 monthly to 3 monthly
Post-transplant HLA antibody
monitoring (new): Weekly in 1st month
Monthly for first 3 months Quarterly for 1st year
Yearly
0
500
1000
1500
2000
2500
3000
3500
4000
4500
5000
5500
6000
6500
7000
2005 2006 2007 2008 2009 2010 2011
Pre-Tx
Post-Tx
AMR
Deceased Donor 4
Living Related Donor 1
Donor in China 5
No. of Patient sample referred for antibody screening
No.
Year
After GRAFT
After GRAFT
Before GRAFT
Allocation according to formula = (HLA matching score) + (60-age) + (duration of dialysis x 3)
HBV +ve HBV +ve
HCV +ve HCV +ve
0 MM 0 MM (share out all clusters)
Silver hair (>60 yr donor) Silver hair recipient
Two donated paediatric kidneys to an adult
Priority given to organ donor and age <13
0.0
0.1
0.2
0.3
0.4
0.6
0.7
0.8
0.9
1.0
0 1 2 3 4 6 7 8 9 10
Graft Survival, DDRT, Donor age >60; Death Not Censored
Time in Years
Sur
viva
l Pro
babi
lity
Donor Age < 60, n=428
Donor Age >60, n=69
P = 0.3835
Donor age 1 Year 5 Year 10 Year
<60 89.21% 79.07% 60.56%
>60 84.80% 70.82% -
0.0
0.1
0.2
0.3
0.4
0.6
0.7
0.8
0.9
1.0
0 1 2 3 4 6 7 8 9 10
Patient Survival, DDRT, Donor age >60
Time in Years
Sur
viva
l Pro
babi
lity
Donor Age < 60, n=428
Donor Age >60, n=69
P = 0.043
Donor age 1 Year 5 Year
<60 95.21% 90.79%
>60 89.54% 82.45%
CTS result
For 1st deceased kidney tx: 10 year patient survival:~70%
CTS result
For 1st deceased kidney tx: 10 yr graft survival: ~50%
0.0
0.1
0.2
0.3
0.4
0.6
0.7
0.8
0.9
1.0
0 1 2 3 4 5 6 7 8 9 11 12 13 14 15 16 17 18 19 20
Patient Survival - First transplants, DDRT Vs LDRT
Time in Years
Sur
viva
l Pro
babi
lity
P=0.0000
1 Year 5 Year 10 Year 20 Year
DDRT 96.08% 90.35% 84.08% 70.36%
LDRT 98.22% 97.12% 94.76% 87.83%
DDRT, n = 3494
LDRT, n = 567
CTS 70%
Hong Kong Result
0.0
0.1
0.2
0.3
0.4
0.6
0.7
0.8
0.9
1.0
0 1 2 3 4 5 6 7 8 9 11 12 13 14 15 16 17 18 19 20
Graft Survival - First transplants, DDRT Vs LDRT, Death NOT Censored
Time in Years
Surv
ival
Pro
babi
lity
P=0.0000 1 Year 5 Year 10 Year 20 Year
DDRT 92.42% 82.40% 69.22% 42.91%
LDRT 95.00% 89.69% 80.79% 56.68%
DDRT, n = 3494
LDRT, n = 567
CTS: 50%
(Death Not Censored)
First Line
Steroid
Azathioprine
Cyclosporin A
Second Line
Tacrolimus
Mycophenolate
Everolimus
Sirolimus
~30% renal transplant patients died with a functioning graft
Main causes of death:
cardiovascular disease
Malignancy
Infection
Management of cardiovascular risks factors and surveillance of malignancy
5%
6%
6%
10%
10%
7%
4%
9%
4%
5%
9%
5%2%
7%
5%
5%
5%
5%
5%
7%2% 7%
14%
29%
7%1%
7%
18%
8%
7%
3%
1%
5%
8%
6%3%1%1%
1%1%
5%
7%
1%1%
1%
2% 2%
2%
3%
16%
2%
1%
4%
2%
1%
PTLDLiverKaposi's SarcomaOral cavityOesophagusStomachColonCervixOvaryUterusAcute leukaemiaLungSkin (non melanoma)ThyroidKidney
Bladder and ureterBreastProstatePancreas
NPCMelanomaOthers
2000
2011
2%
Number of Organs Available
Graft & Patient Survival
Extended Criteria Living Donation
Deceased Donation Rate
Recipient Matching Cold Ischemic Time
Immunosuppressants Manage Co-morbidities
3rd Chinese Transplant
Games
Badminton champion
4 years back in ICU in
hepatic coma
24-Sept-2005 Died on 5-Dec-2005
2012.4.25
Thank You
Don’t take your organs to heaven…
Heaven knows we need them here
Give a call to the Transplant Co-ordinator!
Recommended